Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05744687
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2023-02-16
Brief Title:
Phase IIIII Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-16
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-16
First Submit QC Date:
February 24 2023
Study First Post Date:
2023-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-28
Last Update Post Date:
2024-05-24
Last Update Post Date Type:
ACTUAL